Mit st.10
Antidepresivi ne povzrocajo samomorov.
The Food and Drug Administration (FDA) requires "Black box warnings" on all SSRIs, which state that they double suicidal rates (from 2 in 1,000 to 4 in 1,000) in children and adolescents.[3][7]
It remains controversial whether increased risk of suicide is due to the medication (a paradoxical effect) or part of the depression itself (i.e. the antidepressant enables those who are severely depressed - who ordinarily would be paralyzed by their depression - to become more alert and act out suicidal urges before fully recovered from their depressive episode).[3][8]
The increased risk for suicidality and suicidal behaviour among adults under 25 approaches that seen in children and adolescents.[9] Young patients should be closely monitored for signs of suicidal ideation or behaviors, especially in the first eight weeks of therapy.[10]
Increased risk for quitting medication[edit]
A 2009 study showed increased risk of suicide after initiation, titration, and discontinuation of medication.[11] A study of 159,810 users of either amytriptyline, fluoxetine, paroxetine or dothiepin found that the risk of suicidal behavior is increased in the first month after starting antidepressants, especially during the first 1 to 9 days.[12]
https://en.wikipedia.org/wiki/Antidepressants_and_suicide_risk
IMPORTANT SAFETY INFORMATION AND INDICATIONS
Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies. These studies did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in patients over age 24; there was a reduction in risk with antidepressant use in patients aged 65 and older. In patients of all ages who are started on antidepressant therapy, monitor closely for worsening, and for emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber.
Antidepresivi ne povzrocajo samomorov.
The Food and Drug Administration (FDA) requires "Black box warnings" on all SSRIs, which state that they double suicidal rates (from 2 in 1,000 to 4 in 1,000) in children and adolescents.[3][7]
It remains controversial whether increased risk of suicide is due to the medication (a paradoxical effect) or part of the depression itself (i.e. the antidepressant enables those who are severely depressed - who ordinarily would be paralyzed by their depression - to become more alert and act out suicidal urges before fully recovered from their depressive episode).[3][8]
The increased risk for suicidality and suicidal behaviour among adults under 25 approaches that seen in children and adolescents.[9] Young patients should be closely monitored for signs of suicidal ideation or behaviors, especially in the first eight weeks of therapy.[10]
Increased risk for quitting medication[edit]
A 2009 study showed increased risk of suicide after initiation, titration, and discontinuation of medication.[11] A study of 159,810 users of either amytriptyline, fluoxetine, paroxetine or dothiepin found that the risk of suicidal behavior is increased in the first month after starting antidepressants, especially during the first 1 to 9 days.[12]
https://en.wikipedia.org/wiki/Antidepressants_and_suicide_risk
IMPORTANT SAFETY INFORMATION AND INDICATIONS
Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies. These studies did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in patients over age 24; there was a reduction in risk with antidepressant use in patients aged 65 and older. In patients of all ages who are started on antidepressant therapy, monitor closely for worsening, and for emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber.